The molecular subtypes of breast cancer are specified based on statuses of the oestrogen and progesterone receptors, human epidermal growth factor receptor 2 (HER2) and Ki-67 within the luminal and myoepithelial cells. Here, ERBB2 is linked to breast carcinoma.